Read More Pharma Industry News BioMarin, DiNAQOR to develop gene therapies for rare genetic cardiomyopathies BioMarin Pharmaceutical has signed a preclinical collaboration and license deal with Swiss gene therapy platform company DiNAQOR to… bypharmanewsdailyMay 4, 2020
